CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP/Chief Scientific Officer sold 151 shares at $25.28 ($3,817)
- 4 Open-market sale Chief Scientific Officer sold 622 shares at $26.95 ($16,763)
- 4 Grant or award CEO acquired 15,625 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 5,549 shares at $26.54 ($147,288)
- 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO acquired 20,000 shares (grant or award)
- 4 Open-market sale CEO sold 5,193 shares at $25.83 ($134,135)
- 4 Grant or award CEO acquired 8,283 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 18 · 351 filings